We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+79.42%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$93.4M
AUM Growth
+$9.17M
Cap. Flow
-$3.38M
Cap. Flow %
-3.62%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$3.38M

Sector Composition

Rank Sector Weight
1 Healthcare 89.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAC icon
1
Cartesian Therapeutics
RNAC
$227M
$27.6M 29.5%
64,138
– –
PULM icon
2
Pulmatrix
PULM
$6.21M
$12.6M 13.48%
18,040
– –
GNCA
3
DELISTED
Genocea Biosciences, Inc.
GNCA
$12M 12.83%
246,076
– –
FATE icon
4
Fate Therapeutics
FATE
$293M
$11.3M 12.05%
2,473,186
– –
TTOO
5
DELISTED
T2 Biosystems, Inc
TTOO
$9.87M 10.56%
375
– –
TRVN
6
DELISTED
Trevena, Inc.
TRVN
$7.54M 8.07%
3,286
– –
ATYR
7
aTyr Pharma
ATYR
$47.1M
$6.4M 6.85%
130,571
– –
OCUL icon
8
Ocular Therapeutix
OCUL
$1.85B
$3.56M 3.81%
383,141
-405,582
-51% -$3.38M
DARE icon
9
Dare Bioscience
DARE
$18.6M
$2.67M 2.86%
27,396
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q1 2017 Portfolio in Review

As of Q1 2017, Polaris Venture Management Co V held 9 positions worth $93.4M, up 11% from $84.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V withdrew a net $3.38M in Q1 2017, reducing 1 holding. Its largest reduction was Ocular Therapeutix, cutting an estimated $3.38M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 88% a quarter earlier.

  • Polaris Venture Management Co V's biggest Q1 2017 reduction was Ocular Therapeutix, cutting an estimated $3.38M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $93.4M portfolio in Q1 2017.
  • Polaris Venture Management Co V opened 0 new positions and closed 0 in Q1 2017.
  • Polaris Venture Management Co V's portfolio value rose 11% quarter-over-quarter to $93.4M.

Based on Polaris Venture Management Co V's 13F filing for Q1 2017, filed 15 May 2017.